Media-OutReach Newswire A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Media-OutReach Newswire CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Media-OutReach Newswire HKBU unveils treatment potential of herbal extract compound isoliquiritigenin for pancreatic cancer
Media-OutReach Newswire HKBU unveils treatment potential of herbal extract compound isoliquiritigenin for pancreatic cancer
Media-OutReach Newswire Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Media-OutReach Newswire SMART launches new research group M3S to advance AI, automation and the future of work
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire Fosun Participates in the 3rd BEYOND Expo to Deepen Biotechnology Innovation and Global Development
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
Media-OutReach Newswire Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
Media-OutReach Newswire IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV
Media-OutReach Newswire Led by Legend Capital, GenScript ProBio Completed Nearly USD220m Series C Round of Financing